New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cronos Group Inc.
CRON
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

849M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

849M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

2.22USD
Shape0.03 ( 1.37%)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-33%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

29%

Quote Panel

Shape
Updated October 26, 2024
1W 4.23 % 1M 2.30 % 3M -7.11 % 1Y 29.07 %

Key Metrics

Shape
  • Market Cap

    848.66M


  • Shares Outstanding

    382.28M


  • Share in Float

    200.31M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    2.22


  • Average Volume

    908801


  • Beta

    1.024


  • Range

    1.71-3.14


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.thecronosgroup.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.74x

P/S Ratio

0.81x

P/B Ratio

0.0

Debt/Equity

-52.7%

Net Margin

$-0.1

EPS

How CRON compares to sector?

P/E Ratio

Relative Strength

Shape

CRON

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$129M

Shape363%

2025-Revenue

$0.04

Shape-75%

2025-EPS

$82M

Shape-504%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.07
vs 0.21

Q4.22

arrow
arrow

N/A

-0.14
vs -0.36

Q1.23

arrow
arrow

N/A

-0.03
vs -0.08

Q2.23

arrow
arrow

N/A

-0.02
vs -0.06

Q3.23

arrow
arrow

N/A

-0.00
vs -0.07

Q4.23

arrow
arrow

N/A

-0.05
vs -0.14

Q1.24

arrow
arrow

N/A

-0.01
vs -0.03

Q2.24

arrow
arrow

N/A

-0.02
vs -0.02

Q3.24

arrow
arrow

+257%

0.01
vs -0.00

Q4.24

arrow
arrow

+109%

0
vs -0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+3%

20.9M  vs 20.4M

Q4.22

arrow
arrow

-11%

22.9M  vs 25.8M

Q1.23

arrow
arrow

-20%

20.1M  vs 25M

Q2.23

arrow
arrow

-18%

19M  vs 23.1M

Q3.23

arrow
arrow

+62%

33.9M  vs 20.9M

Q4.23

arrow
arrow

+7%

24.6M  vs 22.9M

Q1.24

arrow
arrow

+25%

25.2M  vs 20.1M

Q2.24

arrow
arrow

+46%

27.8M  vs 19M

Q3.24

arrow
arrow

-10%

30.6M  vs 33.9M

Q4.24

arrow
arrow

+29%

31.7M  vs 24.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.02

Q4.22

arrow
arrow

-7%

-0.07
vs -0.03

Q1.23

arrow
arrow

-2%

-0.02
vs -0.07

Q2.23

arrow
arrow

-1%

-0.01
vs -0.02

Q3.23

arrow
arrow

0%

-0.00
vs -0.01

Q4.23

arrow
arrow

-4%

-0.04
vs -0.00

Q1.24

arrow
arrow

0%

-0.00
vs -0.04

Q2.24

arrow
arrow

-1%

-0.01
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

196

196
vs 202

-3%

Q4.22

arrow
arrow

201

201
vs 196

3%

Q1.23

arrow
arrow

184

184
vs 201

-8%

Q2.23

arrow
arrow

155

155
vs 184

-16%

Q3.23

arrow
arrow

166

166
vs 155

7%

Q4.23

arrow
arrow

174

174
vs 166

5%

Q1.24

arrow
arrow

195

195
vs 174

12%

Q2.24

arrow
arrow

195

195
vs 195

NA

Earnings Growth

Latest News

CRON

marijuanastocks.com

10 hours ago